Table 1.
Main features of clinical cases and Visual Aura Rating Scale (VARS).
| Patient 1 | Patient 2 | Patient 3 | |
|---|---|---|---|
| Gender | Female | Female | Female |
| Migraine age onset | 7 | 5 | 8 |
| Seizure age onset | 11 | 6 | 12 |
| Visual Aura Rating Scale (VARS): | |||
| Duration 5–60 min (three points) | Yes | Yes | Yes |
| Temporal development ≥5 min (two points) | Yes | Yes | Yes |
| Scotoma (two points) | Yes | Yes | Yes |
| Fortification (two points) | No | No | No |
| Homonymus character (one point) | No | No | No |
| Brain MRI findings | None | None | None |
| Treatment | Topiramate 2 mg/kg/day | Valproic acid 20 mg/kg/day, replaced for side effects and poor efficacy with Topiramate 2 mg/kg/day | Topiramate 2 mg/kg/day |
| Outcome | Migraine | Migraine | Migraine/Isolated visual aura |